EP4511509A1 - Détection d'acide nucléique dans une pcr au moyen d'un complexe rapporteur modulaire non spécifique à une séquence cible - Google Patents

Détection d'acide nucléique dans une pcr au moyen d'un complexe rapporteur modulaire non spécifique à une séquence cible

Info

Publication number
EP4511509A1
EP4511509A1 EP23721864.9A EP23721864A EP4511509A1 EP 4511509 A1 EP4511509 A1 EP 4511509A1 EP 23721864 A EP23721864 A EP 23721864A EP 4511509 A1 EP4511509 A1 EP 4511509A1
Authority
EP
European Patent Office
Prior art keywords
signal
sequence
mediator
pcr
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23721864.9A
Other languages
German (de)
English (en)
Inventor
Felix Von Stetten
Tamara Pfaff
Michael Lehnert
Martin Trotter
Nadine Borst
Lisa BECHERER
Helena Gmoser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hann Schickard Gesellschaft fuer Angewandte Forschung eV
Original Assignee
Hann Schickard Gesellschaft fuer Angewandte Forschung eV
Albert Ludwigs Universitaet Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP22191150.6A external-priority patent/EP4265734A1/fr
Application filed by Hann Schickard Gesellschaft fuer Angewandte Forschung eV, Albert Ludwigs Universitaet Freiburg filed Critical Hann Schickard Gesellschaft fuer Angewandte Forschung eV
Publication of EP4511509A1 publication Critical patent/EP4511509A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6823—Release of bound markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification

Definitions

  • target sequences are detected either by dyes that intercalate into the DNA, but which bind non-specifically to all existing DNA double strands, or by DNA probes , which only bind a specific DNA target sequence.
  • DNA probes generate an optical signal change directly (e.g. TaqMan probes) or indirectly (mediator probes in combination with universal reporter molecules) through their cleavage.
  • Optical detectors detect the light emissions generated during the reaction outside the reaction vessel. These detection systems mostly rely on light-absorbing and emitting fluorescence molecules. After being stimulated by light energy of a certain wavelength, these molecules release energy in the form of higher wavelengths, which can be detected using detectors.
  • fluorescence donor or fluorophore molecules whose light energy is to be detected in a specific wavelength range
  • fluorescence acceptor or quencher molecules that lead to a decrease in the fluorescence intensity of a fluorophore when in close proximity
  • fluorescence acceptor or quencher molecules that lead to a decrease in the fluorescence intensity of a fluorophore when in close proximity
  • DNA probes or detection molecules which carry different fluorophore-quencher combinations, each of which emits a fluorescence signal in a specific wavelength range in the presence of a specific DNA sequence.
  • Further developments of this multiplexing detection also enable the detection of multiple target sequences within a wavelength range by considering the fluorescence values quantitatively or combining them with other parameters (e.g. the readout temperature).
  • Two well-known single-part target sequence-specific DNA probes for optical detection are Taqman probes and molecular beacons (Tan et al. 2004; Li et al. 2008; Holland et al. 1991; Rodriguez et al. 2005). These bind target sequence-specifically and are cleaved during PCR, generating a signal.
  • the disadvantage of these probes is their dependence on the target gene sequence, which means that only special regions of a DNA target sequence that must meet certain requirements can be used. For example, attention must be paid to probe length, melting temperature, binding enthalpy, GC content, guanine quenching and complementary sequence fragments. However, these probes are easy to synthesize since usually only two terminal labels are required.
  • fluorogenic detection molecules that are target sequence-unspecific (e.g. mediator probes and universal reporters). These have the disadvantage that their synthesis is much more demanding, but they enable completely new types of sequence detection and have highly optimized fluorescence signal generation.
  • two-part, target sequence-specific detection probe systems (light cycler probes).
  • a fluorescence signal between two neighboring DNA probes is shifted into the longer wavelength spectral range via their fluorophores using FRET, provided both bind correctly to the DNA target sequence and thus create the required distance from one another.
  • FRET fluorophores
  • Molecular beacons consist of an oligonucleotide (oligo) with five to seven complementary bases at the two ends and a terminal fluorophore or quencher (Tyagi and Kramer 1996).
  • oligo oligonucleotide
  • quencher a terminal fluorophore or quencher
  • TaqMan probes also consist of an oligonucleotide and two terminal fluorescent molecules (Heid et al. 1996). However, the oligonucleotide does not form a loop, but rather the fluorescence is transmitted via spatial proximity to the oligonucleotide. When the probe is attached to the target gene and a primer is extended, the probe is degraded by the exonuclease activity of the polymerase used and the fluorophore is thus separated from the quencher. If the fluorescence quenching is too low due to a particularly long probe sequence and the associated large spatial separation of the fluorescence molecules, another internal or terminal quencher can be attached.
  • Taqman probe systems are also used for so-called “intensity multiplexing”. Taqman probes with identical fluorescent labels but different DNA sequences are used to differentiate several target sequences in a multiplex PCR. This is made possible by using the different types of TaqMan probes at different concentrations. However, this process also requires complex fine-tuning of the concentrations and is usually not very precise (Whale et al. 2016).
  • the modular reporter complex described in this invention has the advantage that different fluorescence strengths can be set with constant concentrations of detection molecule complexes by forming complexes from several fluorophore- and quencher-labeled oligonucleotides. This requires less fine-tuning and allows for more precise signal adjustment.
  • detection occurs via a DNA probe that does not carry a fluorescence label. These also bind target sequence-specifically and are cleaved by the exonuclease activity of a polymerase.
  • mediator probe PCR One of these methods is called mediator probe PCR, which was registered for a patent by the University of Freiburg in 2012.
  • MP Mediator Probe
  • UR Universal Reporter
  • PCR amplification of the target sequence only part of a mediator probe binds in a sequence-specific manner and is cleaved by the exonuclease activity of the polymerase.
  • a second part of the mediator probe, the mediator which did not previously bind to the sequence, is separated. If no target sequence is present, the mediator probe remains intact. After the mediator is separated, it will again bind to a universal reporter.
  • a universal reporter is target sequence-independent and, in addition to the mediator binding site, also has a fluorophore and quencher modification as well as a conformation that brings both modifications into spatial proximity to one another.
  • this spatial proximity is eliminated, e.g. by splitting off the fluorophore; which creates a fluorescence signal of a specific wavelength.
  • This method has the advantage that there is a separation between probe binding to the DNA sequence and fluorescence signal generation. This allows clear guidelines to be set for mediator probe design, universal reporters can be optimized to a great extent once and then used for multiple sequences, and this two-part process also provides double control, which makes signal generation very specific (Lehnert et al. 2018; Wadle et al.
  • a technology was developed by Seegene Inc., which is also based on the separation of DNA sequence detection and signal generation via two detection molecules in real-time PCR.
  • an unlabeled PTO probe binds to a DNA target sequence, is cleaved and releases a fragment, which then forms an extended duplex with a fluorescently labeled target sequence-nonspecific detection molecule (CTO molecule).
  • CTO molecule fluorescently labeled target sequence-nonspecific detection molecule
  • This process is used to influence signal generation over different lengths of these detection molecules. This makes it possible, for example, to differentiate between several target sequences in the same detection channel by reading the signal at defined, predetermined temperatures.
  • a CTO is a single molecule that places corresponding requirements on the synthesis.
  • Another patent also uses reading at different temperatures in one approach and can be interpreted as a further development of the above-mentioned technology from Seegene (PCT / CN2018 / 084794).
  • an extended reporter molecule is melted after detection.
  • a reporter molecule can be used to differentiate between different target sequences.
  • the patent W02013079307A1 Bifunctional oligonucleotide probe for universal real-time multi-analyte detection claims the system of mediator probe technology.
  • a mediator probe is activated by extending a primer (auxiliary molecule 1) to the target sequence (target molecule) using a polymerase (auxiliary molecule 2). Due to the exonuclease activity of the polymerase, the mediator probe is cleaved and can then bind to the universal reporter (UR) (mediator hybridization sequence). Here it acts as a primer after its cleavage. As a result, it is extended by the polymerase and thus separates the fluorophore and quencher on the universal reporter.
  • UR universal reporter
  • Patent WO2018114674A1 for the loop-mediated isothermal amplification method with mediator-displacement probes claims a universal reporter with at least one oligonucleotide and at least one fluorophore and quencher for a LAMP reaction.
  • a LAMP continuously has a uniform temperature, which means that an equilibrium is quickly established and maintained, which allows individual molecules to bind to each other permanently and thus no signal in the initial state generate.
  • Biorad patent (US 9921154 B2), which is only granted in the USA. This also claims the detection of multiple target sequences in identical detection channels in a digital PCR, but only describes sequence-specific hydrolysis probes marked with fluorophore and quencher or intercalating dyes for such detection. Further patents from Biorad also describe the differentiation of different target sequences, sometimes in a channel. However, according to current understanding, these can only be used effectively if there is a significant overcrowding of the drops.
  • PCR is the gold standard method for amplifying individual DNA sequences and making them detectable.
  • DNA or cDNA in the case of RNA either intercalating dyes or DNA probes are used.
  • intercalating dyes bind non-specifically to all existing double-stranded DNA molecules, which means that direct sequence-specific detection in PCR is not possible.
  • DNA probes are signal-generating DNA sequences that are complementary to the respective sequence section of a PCR product and can therefore specifically detect and quantify them. This method is used in particular in real-time PCR and digital PCR.
  • DNA probes either have a biochemical modification themselves in order to generate a signal in the presence of a DNA target sequence during PCR (e.g. Taqman probes) or activate a second detection molecule, which generates a signal independently of the target sequence (e.g. Mediator probes in combination with target sequence-unspecific universal reporters).
  • the invention relates to a method for detecting at least one target nucleic acid sequence, comprising the steps: a. Providing at least one target sequence-unspecific modular reporter complex, comprising at least one label and at least two oligonucleotides, namely i. comprising a base strand
  • At least one signal oligo binding site ii. at least one signaling oligo wherein the at least one signal oligo binding site of the base strand and the at least one signal oligo hybridize with one another, but are not covalently linked and together form a signal complex
  • b. Providing at least one mediator probe, the mediator probe comprising an oligonucleotide with at least one probe sequence and at least one mediator sequence, the at least one probe sequence having an affinity for at least one target nucleic acid sequence, and the at least one mediator sequence having an affinity for at least one mediator -Binding site on the base strand of the at least one target sequence-unspecific modular reporter complex, c. PCR amplification of at least one nucleic acid sequence, i.e.
  • Binding a probe sequence of at least one mediator probe to the at least one target nucleic acid sequence e. Cleavage of the probe sequence of the at least one mediator probe bound to the at least one target nucleic acid sequence by a PCR polymerase with nuclease activity during the PCR amplification, whereby the mediator sequence is released, f. Binding at least one released mediator sequence to a mediator binding site of the at least a target sequence-unspecific modular reporter complex, g. Extension of the sequence of at least one Mediator sequence bound to a Mediator binding site by a PCR polymerase, the binding of the at least one signal oligo binding site and the at least one signal oligo hybridized to one another being broken, whereby a signal change is initiated, h. Detection of at least one signal change as evidence of the at least one target nucleic acid sequence.
  • the at least one label of the target sequence-unspecific modular reporter complex comprises at least one fluorophore and/or at least one quencher.
  • the present method is used to detect at least one nucleic acid sequence during a PCR reaction, during which a mediator probe is cleaved (by an exonuclease activity of the polymerase).
  • the cleavage product is a mediator, which subsequently binds to a target sequence-unspecific modular reporter complex and, via a subsequent reaction, initiates a signal change that serves to detect the DNA sequence.
  • the target sequence-unspecific modular reporter complex consists of This embodiment preferably consists of at least two oligonucleotides which are not covalently linked, with at least one oligonucleotide of this complex having at least one label which initiates a signal change and which preferably comprises at least one fluorophore and at least one quencher.
  • an oligonucleotide of the target sequence-unspecific modular reporter complex (base strand) preferably has at least one binding site for at least one mediator sequence (also referred to herein as a receptor) and at least one binding site for a signal oligo.
  • the second oligonucleotide of the complex is the signaling oligo, which binds to the base strand (forming a signaling complex). As long as the mediator probe is uncleaved, the target sequence-unspecific modular reporter complex remains in its basic state during the detection or readout process.
  • the target sequence-unspecific modular reporter complex is broken up on the signal complex in such a way that the marking or markings on the base strand and / or on the signal oligo are separated from each other, whereby a Change of the signal to the basic state and thus a signal change is initiated, which serves to detect the DNA target sequence.
  • steps d - h of the method according to the invention can occur continuously in each cycle during the PCR amplification; this is preferably the case if the PCR amplification is a real-time PCR or qPCR.
  • steps d - h are repeated during the PCR amplification in each PCR cycle, the PCR amplification being a real-time PCR or qPCR.
  • steps d - g of the method according to the invention can take place during the PCR amplification, with step h taking place afterwards; this is preferably the case if the PCR amplification is a digital PCR or endpoint analysis.
  • steps d - g are repeated during the PCR amplification in each PCR cycle, and then step h occurs, where the PCR amplification is a digital PCR or endpoint analysis.
  • the detection step h of the method according to the invention preferably takes place separately, following the PCR amplification reaction.
  • the modular reporter system according to the invention for target sequence-unspecific detection distinguishes itself from the previously known detection systems through the flexible use of different oligonucleotides with different labels and surprisingly has the same performance indicators in a PCR as current one-part detection molecules.
  • the modular structure offers various advantages such as the flexibly adaptable design to specific device conditions, the uniformity of the signal generation reaction between different detection methods or the inexpensive, simple production as well as completely new multiplex detection methods.
  • the system and its functionality have not yet been described in a patent or in the literature for nucleic acid detection in a PCR.
  • the core of the invention is the modular target sequence-independent modular reporter complex (see Figure 2A for an exemplary embodiment) made of non-covalently linked oligonucleotides.
  • This system has all the advantages of the various target sequence-specific detection systems as well as target sequence-unspecific detection molecules and combines them with increased flexibility in the design of such detection molecules, which lead to completely new detection methods.
  • the system can be used without any problems in a PCR with cyclical temperature changes and the associated melting of the DNA strands in each cycle.
  • the results of the present examples which are also shown in FIGS. 6-8, provide evidence that the modular Universal Reporter (UR) system according to the invention even exceeds the prior art in terms of functionality.
  • significantly cheaper production can be achieved with at least as good performance parameters.
  • Another advantage of the system is the possibility of flexible adaptation of the universal probe according to the invention. Different fluorophores and quenchers can be conveniently combined and investigated and multiplex reactions can be expanded. Different labels can be used to distinguish between different probes in a fluorescence channel.
  • the invention thus provides a dynamic, inexpensive and universal detection system.
  • the basic structure of the modular system of the target sequence-independent modular reporter complex consists of a basic strand.
  • This preferably has at least one binding site for a mediator (receptor complex) and at least one binding site for a signal initiation oligonucleotide (or “signal oligo” for short) and thus forms a signal complex (examples of embodiments comprising a signal complex and a receptor complex can be found, for example, in Figures 2, 4 and 5).
  • the base strand and at least one signal oligo together form a complex (see e.g. Figure 2B for an exemplary embodiment).
  • at least one of these strands has a label that can detect a structural change in this complex.
  • This structural change preferably represents the separation, displacement, or (re)cleavage, detachment or enzymatic digestion of the signal oligo from the base strand, which preferably leads to a signal change.
  • the modular structure results from several possible signal initiation oligonucleotides (or signal oligonucleotides, “signal oligos” for short) as well as additional markings, which can be attached both to the signal oligonucleotides and to the base strand (see, for example, FIG. 2B, marking positions Li to Li am signal complex).
  • FIG. 2B marking positions Li to Li am signal complex.
  • the base strand comprises at least one signal oligo binding site to which two or more signal oligos are hybridized, and wherein the two or more signal oligos and/or the base strand have one or more markers at the at least one signal oligo binding site.
  • a mediator probe binds to the amplified DNA target sequence during a PCR detection reaction.
  • a mediator probe is preferably an oligonucleotide and has a sequence-specific probe section which binds to the target sequence and is protected at the 3', and a target sequence-unspecific section, called mediator, which, apart from one nucleotide which is common to the mediator and probe, does not bind to the Target sequence binds.
  • mediator a target sequence-unspecific section
  • the mediator is cleaved from the probe, with the common base remaining on the mediator ( Figure 1).
  • the mediator is now no longer blocked by the probe section and can now bind to the target sequence-nonspecific reporter complex and be extended here.
  • the mediator binds to the receptor complex of the base strand of the target sequence-independent modular reporter complex.
  • the mediator is then extended along the base strand by the polymerase, whereby the signaling complex is broken up in such a way that individual components and/or molecules of this complex are cleaved off, thereby initiating a signal change compared to the original state ( Figure 2A).
  • a mediator probe therefore comprises an oligonucleotide and a sequence-specific probe portion that binds to the target sequence and is 3′-protected.
  • This protection at the 3' end may be a block group (protecting group), e.g. a chemical block or protecting group, which in some embodiments comprises a chain of three carbon atoms.
  • Protecting the mediator probe at the 3' end preferably prevents the (unspecific) extension of the sequence strand by a polymerase during an amplification reaction.
  • the mediator probe can comprise any protecting or blocking group which is suitable for preventing (non-specific) extension of the mediator probe sequence strand by a polymerase during an amplification reaction.
  • the mediator probe is protected against (non-specific) polymerase extension by means other than a block group (protecting group) at the 3' end.
  • a mediator probe does not include a block group (protecting group) at the 3' end and is not protected against (non-specific) polymerase extension.
  • a 3'-end protected mediator probe may include a “C3 spacer”.
  • a C3 spacer may be a chemical block group, which in some embodiments includes a chain of three carbon atoms. This “C3 spacer” thus preferably prevents (unspecific) polymerase extension of the mediator probe sequence strand.
  • the person skilled in the art will find typical block groups that are suitable depending on the embodiments (protecting groups). Also, based on the present disclosure of the invention, one skilled in the art will know how to select appropriate block groups (protecting groups) as routine adaptations of the invention described herein.
  • no fluorescence signal change is generated by the at least one fluorophore when the at least one signal oligo is hybridized with the at least one signal oligo binding site of the base strand, with either the at least one quencher being localized at the at least one signal oligo binding site of the base strand and the at least one fluorophore on the at least one signal oligo or vice versa, and wherein in step g at least one fluorophore and at least one quencher are separated, whereby a signal change is initiated.
  • a fluorescence signal change preferably describes a significant, differentiable and/or characteristic change in the fluorescence signal, which is clearly demarcated or different from potential basic or background signals or background or background noise. Therefore, in the context of the invention, a fluorescence signal change preferably describes a significant, differentiable and/or characteristic change in the fluorescence signal, and not a fluorescence base or background signal or background or background noise.
  • the at least one label further comprises at least one fluorophore and at least one quencher, wherein both the at least one quencher and the at least one fluorophore are localized on the at least one signal oligo, and wherein in step g. (extension of the sequence of at least one Mediator sequence bound to a Mediator binding site by a PCR polymerase) the at least one signal oligo is cleaved by the PCR polymerase, whereby the at least one fluorophore and the at least one quencher are separated, whereby a signal change is initiated.
  • the cleavage of the signal oligo from the signal oligo binding site of the base strand by a PCR polymerase may occur either by enzymatic digestion or cleavage of the signal oligo by the polymerase (e.g., by exonuclease activity of the polymerase) or by another mechanism, e.g., by the signal oligo the polymerase is detached from the base strand, separated from it or displaced.
  • the process according to the invention for detecting DNA sequences by means of PCR in combination with optical readout comprises a novel system of individual oligonucleotides, preferably DNA oligonucleotides. These form such a target sequence-independent modular reporter complex without covalent bonds.
  • This target sequence-independent modular reporter complex surprisingly has all the advantages and performance indicators of one-part target sequence-dependent DNA probes or one-part target sequence-independent detection molecules.
  • the target sequence-independent modular reporter complex preferably consists of at least two DNA sequences which specifically bind to one another and carry chemical modifications which initiate signal generation during a PCR reaction (eg DNA amplification).
  • signals of different strengths can be generated by using different target sequence-independent reporter complexes with a different number of labels and/or different numbers of signal oligos, which make the activation of these target sequence-independent reporter complexes distinguishable.
  • markings e.g. different color and/or intensity
  • the signal of a signal oligo with one red marker can be differentiated in color from the signal of a signal oligo with two or three red markers based on the intensity differences of the signal generated, or from the signal of a signal oligo with one red and one green marker.
  • not only individual markings but also different combinations of different fluorophore colors and/or the number of fluorophores (signal intensity) are provided, each of which encodes a signal that is specific for a target sequence. This ability to combine signals is advantageous for detecting multiple target sequences at the same time (in the same PCR reaction).
  • the base strand has at least a first and a second label, the signal change caused by the at least one first label being characteristic of the first target nucleic acid sequence, and the signal change caused by the at least one second label being characteristic of the second target nucleic acid sequence is.
  • the signal changes characteristic of the at least first and the at least second target nucleic acid sequence differ from each other by their color and/or their fluorescence or signal strength.
  • a signal complex comprises at least two signal oligos with two labels, the common signal being characteristic of a target sequence.
  • the detection of the signal change includes an analysis of the signal change as a function of the detection temperature.
  • a target sequence-independent modular reporter complex according to the invention has a very high stability in the initial state under PCR conditions.
  • the initial signal is comparable to that produced by a one-piece DNA probe or a one-piece Target sequence-independent reporter is generated.
  • the entire resulting PCR detection system according to the invention has performance indicators comparable to current PCR detection methods based on one-part detection molecules. This is the case even though this complex of a target sequence-independent modular reporter has to be separated with each cycle of a PCR and formed again before the signal is read out.
  • the system according to the invention thus increases the efficiency of signal generation and is also suitable for the simultaneous detection of several DNA target genes in a PCR reaction (multiplex PCR). It also offers completely new possibilities for detecting and differentiating multiple DNA sequences in the same channel of a PCR detector.
  • steps c take place. until h. as part of a reaction selected from the group comprising PCR, digital PCR, RT-PCR, digital RT-PCR, real-time/qPCR, droplet PCR, or any combination of these.
  • the target sequence-independent modular reporter complex according to the invention is at the same time flexible in design and, on the other hand, the individual components are inexpensive to develop and produce.
  • the system according to the invention enables the production of universal microarrays. Overall, this represents a significant improvement over the state of the art.
  • the invention relates to a kit for carrying out the method according to one of the preceding claims, comprising: at least one oligonucleotide primer at least one mediator probe at least one signal oligo at least one base strand at least one buffer PCR polymerase.
  • the oligonucleotide primers preferably at least one pair of oligonucleotide primers, the at least one signal oligo, the at least one mediator and/or the at least one base strand can be configured or suitable for the specific detection of one or more different target sequences.
  • the kit according to the invention can be used to carry out the method according to the invention.
  • the kit can thus be used for the specific amplification and/or detection of target sequences within the scope of the method according to the invention.
  • the specific amplification and/or detection reaction is a PCR, qPCR, real-time PCR, droplet PCR and/or digital PCR.
  • inventions described for one aspect of the invention may also be embodiments of any of the other aspects of the present invention. Accordingly, embodiments described for the method according to the invention can also be embodiments of the kit according to the invention. Additionally, any embodiment described herein may also include features of any other embodiment of the invention.
  • the various aspects of the invention are united, benefit from, are based on and/or are, through the common and surprising discovery of the unexpected advantageous effects of the present method, namely the optimized PCR detection of target sequences by reporter complexes, which themselves are non-specific to the target sequence associated with it.
  • target sequence-unspecific reporter complex describes a complex of target sequence-unspecific nucleic acid oligonucleotides (e.g. DNA oligonucleotides) for signal generation during PCR in the presence of DNA target sequences.
  • a target sequence-unspecific reporter complex comprises at least one label and at least two oligonucleotides, namely 1) a base strand comprising at least one mediator binding site and at least one signal oligo binding site, and 2) at least one signal oligo, wherein the signal oligo binding site of the base strand and that at least one signal oligo hybridize with each other, but are not covalently linked.
  • a base strand describes a nucleic acid oligonucleotide (eg a DNA oligonucleotide) and part of the target sequence-unspecific reporter complex.
  • a basic strand serves as the basis for the connection of signaling oligos and mediators, which form a signaling complex and receptor complex. Therefore, a base strand preferably comprises at least one mediator binding site and at least one signal oligo binding site.
  • a base strand includes one or more mediator binding sites and/or signal oligo binding sites.
  • a base strand can have at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 25, 30, 40 or even include 50 Mediator binding sites.
  • a basic strand can also have at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 25, 30, 40 or even include 50 signal oligo binding sites.
  • a base strand comprises between 1 and 10 mediator binding sites and between 1 and 10 signal oligo binding sites.
  • a Mediator binding site can correspond to one or more signal oligo binding sites, in other words, an (activated) Mediator bound to a Mediator binding site can be activated or activated when extended by a (PCR) polymerase. the degradation, digestion, (ab)cleavage or release of one or more signal oligos from one or more signal oligo binding sites, preferably located upstream (towards the 5' end).
  • a basic strand may comprise one or more signaling complexes and one or more receptor complexes, where a signal oligo complex may comprise at least one signal oligo binding site and (in the non-activated state) at least one signal oligo, and a receptor complex may comprise at least one mediator Binding site may include.
  • a “signal initiation oligonucleotide”, “signal initiation oligo” or “signal oligo” for short is a nucleic acid oligonucleotide (preferably a DNA oligonucleotide) and part of the signaling complex, which initiates a signal change in the presence of a target sequence by itself and/or parts of it are split off or broken up by the signal complex.
  • the terms signal initiation oligonucleotide, signal initiation oligo and signal oligo are to be considered equivalent and interchangeable.
  • a “label” may describe one or more fluorophores or one or more quenchers. Accordingly, in the context of the invention, a base strand and/or a signal initiation molecule or signal oligo in embodiments may carry or comprise one or more fluorophores and/or quenchers.
  • the proximity of a fluorophore to the quencher prevents detection/detection of its fluorescence, with degradation of the signal oligo by hydrolysis by the 5'-to-3' exonuclease activity of the PCR polymerase used for the amplification reaction, the reporter quencher -Proximity interrupts and thus enables an unquenched emission of fluorescence, which can be detected with a laser after excitation.
  • a target sequence-unspecific modular reporter complex comprises at least one fluorophore and at least one quencher (these are preferably present “in pairs”), the quencher preferably suppressing the fluorophore signal as long as the signal oligo is hybridized at the signal oligo binding site , wherein the at least one fluorophore and the at least one quencher are relative to each other within the target sequence-unspecific modular reporter complex either in the cis position (both on either the signal oligo or on the base strand) or in the trans position (one of the two markings is on the base strand, the others can be localized at the signaling oligo, or vice versa).
  • a base strand can contain zero, one or more markings, for example none or at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 marks, or exactly 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, There may be 19, 20 or even 25 marks.
  • a base strand includes zero, 1, 2, 3, or up to 5 markers. In other embodiments, a base strand includes zero, 1, 2, 3, 4, 5, or even more than 5 markers.
  • a signal oligo can contain none, one or more markings, for example no or at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, or even 20 markings, or exactly 0. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 markings may be present.
  • a signal oligo includes none, 1, 2, 3, or up to 5 markers.
  • a signal oligo includes zero, 1, 2, 3, 4, 5, or even more than 5 tags.
  • a “mediator” refers to an oligonucleotide and part of the receptor complex, which can be extended along the “basic strand” by the polymerase.
  • a “mediator probe” describes a nucleic acid oligonucleotide, preferably a DNA oligonucleotide, which establishes the connection between the target sequence and the target sequence-independent (modular) receptor by binding to it during PCR in the presence of a DNA target sequence Exonuclease activity of the polymerase is cleaved and a mediator sequence is released, which then binds to a base strand and forms a receptor complex together with the base strand.
  • a “C3 spacer” is preferably a chemical block group (protecting group), which preferably comprises a chain of three carbon atoms. This block group (protecting group) preferably serves to prevent (unspecific) polymerase extension of the strand.
  • protecting group a chemical block group
  • This block group (protecting group) preferably serves to prevent (unspecific) polymerase extension of the strand.
  • suitable - C3 spacers / block groups (protecting groups) are known to the person skilled in the art and, based on the present disclosure of the invention, the person skilled in the art knows how to use suitable C3 spacers / block groups (protecting groups) as routine adaptations of those described herein Must select invention.
  • nucleic acid refers to nucleic acid molecules including, without limitation, DNA, ssDNA, dsDNA, RNA, mRNA, tRNA, lncRNA, ncRNA, microRNA, siRNA, rRNA, sgRNA, piRNA, rmRNA, snRNA, snoRNA, scaRNA, gRNA or viral RNA.
  • Nucleic acid sequences herein refer to a sequential arrangement of nucleotides, the nucleotides being represented by their nucleobases in guanine (G), adenine (A), cytosine (C) and thymine (T) in DNA and uracil (U) in RNA.
  • a nucleic acid sequence here can also refer to the sequence of consecutive letters or nucleobases (consisting of G, A, C and T or U), which represent the actual sequence of consecutive nucleic acids in a DNA or RNA strand.
  • This nucleic acid sequence can be identified and characterized biochemically and bioinformatically using DNA or RNA sequencing or can be specifically detected by complementary nucleic acid probes (e.g. in embodiments herein by mediator probes), e.g. as part of a PCR, real-time PCR or detection reaction digital PCR.
  • the sequence analysis can also include the comparison of the nucleic acid sequence obtained or a detection signal specific therefor with one or more reference nucleic acid sequences and/or with the detection signals of housekeeping genes.
  • nucleotide can be abbreviated as “nt”.
  • base pair two nucleobases bound together via hydrogen bonds
  • a “target sequence” describes any nucleic acid sequence of interest that is to be detected by the method according to the invention.
  • a target sequence can preferably be a DNA or RNA sequence.
  • a target sequence can be a part or the represent the entire nucleic acid sequence of a target DNA.
  • a mediator probe preferably comprises a sequence which is wholly or partially complementary to the nucleic acid sequence of the target sequence or a part thereof. In some embodiments, this mediator probe sequence is 100%, 99%, 95%, 90%, or 80% complementary to the target sequence.
  • a mediator probe may, in some embodiments, tolerate one or more mismatches to the target sequence and still bind to it. In other embodiments, the mediator probe only binds to a target sequence if it matches the target sequence 100%.
  • nucleic acid amplification reaction refers to any method that involves an enzymatic reaction that enables the amplification of nucleic acids.
  • a preferred embodiment of the invention relates to a polymerase chain reaction (PCR).
  • PCR Polymerase chain reaction
  • PCR is the gold standard method for quickly producing millions to billions of copies (full copies or partial copies) of a given DNA sample, allowing the amplification of a very small DNA sample to a sufficiently large amount becomes.
  • PCR amplifies a specific region of a DNA strand (the target DNA sequence) depending on where the primers used bind to start the amplification reaction.
  • Almost all PCR applications use a heat-stable DNA polymerase enzyme, such as. B. Taq polymerase.
  • Quantitative PCR or “real-time PCR”, represents a specific form of PCR and is a standard method for detecting and quantifying a specific target sequence or for quantifying the level of gene expression in a sample Real time.
  • fluorescently labeled probes or nucleic acids e.g. mediator probes
  • a complementary sequence e.g. a target sequence
  • the presence and the amplification of target sequences is monitored in real time after or during each PCR cycle.
  • a real-time PCR makes it possible to monitor the progress of an ongoing amplification reaction as it occurs (i.e. in real time). Data is therefore collected throughout the PCR reaction and not at the end point as with conventional PCR. Measuring reaction kinetics in the early phases of PCR offers significant advantages over conventional PCR detection.
  • reactions are characterized by the point in time during the cycle at which amplification of a target is first detected, rather than by the amount of target accumulated after a fixed number of cycles, as in classical PCR. The higher the starting copy number of the nucleic acid target, the more likely a significant increase in fluorescence is to be observed.
  • Real-time PCR enables analysis using optical signals that are used to detect a specific PCR product (the target sequence), using specific fluorochromes or fluorophores. An increase in DNA product during a PCR therefore results in an increase in the fluorescence intensity measured at each cycle. Using different colored labels, fluorescent probes can be used in multiplex assays to monitor multiple target sequences. While real-time qPCR depends on the relative amount of target nucleic acid being determined in each amplification cycle, "digital PCR", on the other hand, enables the absolute amount of target nucleic acid to be determined based on Poisson statistics, which is determined following an endpoint analysis. PCR amplification is used to calculate the target nucleic acid amount.
  • the steps before amplification are usually comparable or similar between digital PCR and qPCR.
  • all nucleic acid molecules are preferably pooled and then amplified and analyzed
  • digital PCR the nucleic acid molecules are preferably divided as best as possible into individual partitions (e.g. emulsion drops, cavities or gel beads), so that the PCR runs as a single reaction in each partition (in the case of emulsion drops, this reaction is often referred to as droplet PCR or digital droplet PCR) and allows each partition to be analyzed separately.
  • the random division of the nucleic acid molecules into individual partitions occurs according to the Poisson distribution.
  • Digital PCR analysis then applies Poisson statistics to determine the average number of nucleic acid molecules per partition (none, one, or more). Statistical Poisson analysis of the number of positive and negative reactions provides precise absolute quantification of the target sequence.
  • the invention relates to a method, wherein the amplification is a multiplex PCR with more than one pair of primers.
  • Multiplex PCR is a variant of standard PCR in which two or more target sequences can be amplified and/or detected simultaneously in the same reaction by using at least one pair of primers in the reaction.
  • a “signal change” describes a fluorescence signal change.
  • This signal change is preferably a significant, differentiable and/or characteristic change in the fluorescence signal, which is clearly demarcated or different from potential basic or background signals or background or background noise.
  • a signal change preferably describes a significant, differentiable and/or characteristic change in the fluorescence signal, and not a fluorescence base or background signal or background or background noise.
  • this signal change can mean an increase in the fluorescence intensity, in other words an increase in the fluorescence signal.
  • a signal change is the decrease in fluorescent signal.
  • the increase in a fluorescence signal is preferably due to the fact that the number of target sequence amplicons increases as a result of an amplification reaction and thereby the activation of associated signal complexes. Accordingly, the number of resulting (cleavages, digestions and/or separations of the respective signal oligos from their binding site on the associated base strands increases, whereby at least one fluorophore is released and/or separated from its quencher (i.e. the distance between quencher and fluorophore in such a way increases that the fluorescence signal is no longer quenched by the quencher).
  • an increase (increase in number) of released and/or non-quenched fluorophores thus leads to an increase in the fluorescence signal, which is specific and indicative of a target sequence.
  • the more target sequences are present and bound by mediator probes in a PCR reaction the more the fluorescence signal increases.
  • the fluorescence signal is proportional or approximately proportional to the amount of the corresponding target sequence for which the fluorophore signal (eg its color) is specific/characteristic. Since in the context of a digital or "droplet" PCR there is preferably only one target sequence per reaction space (e.g. partition, emulsion drop), the signal increases increasingly with the number of target sequence amplicons per reaction space. In preferred embodiments, there is ideally a uniform distribution of max.
  • the intensity / strength of a, preferably specific for a target sequence respective marking as well as the maximum achievable signal strength/intensity depend on the number of markings per signal oligo and signal complex and/or the type of marking (e.g. type of fluorophores and/or quencher).
  • Fluorophore (or fluorochrome, similar to a chromophore) is a fluorescent chemical compound that can re-emit light when excited by light.
  • Fluorophores for use as labels in the construction of labeled probes of the invention include, without limitation, rhodamine and derivatives such as Texas Red, fluorescein and derivatives such as 5-bromomethylfluorescein, Lucifer Yellow, IAEDANS, 7-Me2N-coumarin -4 -Acetate, 7-OH- 4-CH3-coumarin-3-acetate, monobromobimane, pyrene trisulfonates such as Cascade Blue and monobromo-trimethyl-ammoniobimane, 7-NH2-4CH3-25-coumarin-3-acetate (AMCA), FAM, TET , CAL Fluor Gold 540, JOE, VIC, Quasar 570, CAL Fluor Orange 560, Cy3, NED, Oyster 556, TMR, CAL Fluor Red
  • Quenching refers to any process that reduces the fluorescence intensity of a given substance. Quenching (“quenching”) is the basis for Förster resonance energy transfer (FRET) assays or static or contact quenching assays or a combination of both the. FRET is a dynamic quenching mechanism because energy transfer occurs while the donor is in the excited state. Contact quenching requires immediate spatial proximity in the form of physical contact between donor and quencher. A “quencher” is a molecule that quenches the fluorescence emitted by the fluorophore when it is excited by the light source of a PCR cycler or detection device.
  • Quenchers for use as labels in the construction of labeled signal oligos and/or base strands of the invention include, but are not limited to, DDQ-I, Iowa Black, Iowa Black FQ, QSY-9, BHQ-1, QSY-7, BHQ- 2, DDQ-II, 22 Eclipse, Iowa Black RQ, QSY-21, BHQ-3 Dabcyl, QSY-35, BHQ-0, ElleQuencher, BMN-Q1, BMN-Q2, BMN-Q60, BMN-Q-535, BMN-Q590, BMN-Q620, BMN-Q650.
  • suitable reporter-quencher pairs and knows which ones should be selected for a particular application.
  • a real-time Mediator sample PCR was carried out on the Rotor-Gene Q 60006-plex from the manufacturer Qiagen.
  • the temperature profile consists of an initial denaturation for 2 min at 95 °C and subsequent 45 cycles (1 cycle corresponds to: 10 seconds at 95 °C, 80 seconds at 58 °C and a further 10 seconds at 58 °C for fluorescence readout).
  • Another embodiment includes performing a digital PCR in the Qiagen QIAcuity system according to the results shown in Figure 7.
  • the temperature profile results from an initial denaturation over a period of 2 minutes. This is followed by repeating a cycle 40 times, which consists of 15 seconds of denaturation at 95 °C and a subsequent binding step at 58 °C for 30 seconds.
  • a digital multiplex Mediator sample PCR can be carried out using three different mediator probes for three different target sequences, with the following three complexes each consisting of a base strand and as modular reporter complexes for the three respective mediator probes one or two signal oligos can be used:
  • Modular reporter complex 1 sequence ID11 (SEQ ID NO: 11), sequence ID 12 (SEQ ID NO: 12)
  • Modular reporter complex 2 sequence ID 13 (SEQ ID NO: 13), sequence ID 14 (SEQ ID NO: 14)
  • Modular reporter complex 3 sequence ID 15 (SEQ ID NO: 15), sequence ID 11, sequence ID 13
  • the digital PCR can be carried out analogously to the experimental description of the exemplary embodiment for digital PCR and the procedure according to experiment 7, whereby a fluorescence signal must be measured in at least two suitable wavelength ranges in order to obtain and evaluate the signal patterns shown in Table 2 can.
  • the forward and reverse primers for Hd [sequence ID: 08 and 09] were used in 0.1 pM as well as 0.2 pM of the corresponding mediator probe [sequence ID: 10].
  • the state of the art universal reporter (UR) was compared with the two-part reporter and two multiplex variants were tested.
  • the concentrations of the varying fluorescence-generating probes for the individual reactions were chosen as follows:
  • the UR (sequence ID (SEQ ID NO): 01) was used in 0.05 pM, the two-part reporter consisting of the signal oligo and the base strand [sequence ID ( SEQ ID NO): 02 and 03] were used at 0.08 pM each.
  • a 26K 24-well nanoplate was filled with 40 ⁇ l reaction volume per well.
  • the fluorescence was measured on the QIAcuity system in the green color spectrum (excitation: 463-503 nm, emission: 518-548 nm) and the standard settings, which are known to the person skilled in the art, were retained.
  • the result for the experiment is the results shown in Fig. 7, which were evaluated using the QIAcuity Software Suite 1.2.18 using absolute quantification.
  • A1 corresponds to the NTC
  • A2 to the PTC for the prior art (UR Green, [Sequence ID (SEQ ID NO): 01]).
  • Well C1 and C2 show the results of the NTC and PTC for the two-part reporter system [Sequence ID (SEQ ID NO): 02 and 03], Table 1: Primer sequences used for the exemplary embodiments with names and (internal) modifications. The sequences for the multiplex variants are only used for the exemplary embodiment of the experiment in FIG. 6.
  • Table 2 Primer sequences used with name and (internal) modification for the exemplary embodiment (multiplex detection) according to the method shown in FIG. 9.
  • the target sequence-nonspecific modular reporter complex can consist of a basic strand with a label at the 5' end and a signal initiation strand with a label at the 3' end ( Figure 4B).
  • a fluorophore and a quencher are attached to each marking point, which means that no fluorescence signal is generated in the initial state.
  • Both the quenching efficiency and the fluorescence intensity of different dyes can be optimized for PCR application more easily, since only one strand has to be exchanged at a time and can also be used directly (Figure 4B).
  • the system is ideally suited for this, as the behavior and performance parameters of the modifications and markings can change slightly depending on the sequence and connection variant.
  • the target sequence-unspecific modular reporter complex according to the invention used in this way is significantly cheaper than probe systems of the prior art and shows at least the same performance in PCR and digital PCR as one-piece universal reporters of the prior art. This was proven by the results of comparative experiments, as shown in Figures 6 (PCR analysis) and 7 (dPCR analysis).
  • the target sequence-independent modular reporter complex according to the invention therefore allows the combination of fluorophores and quenchers to be optimized much more efficiently compared to a one-part, double-labeled oligonucleotide (prior art).
  • the two-part target sequence-unspecific reporter for optimizing fluorescence signals shows very good and improved performance both in comparison to the universal reporter currently used in the state of the art and with regard to its use for investigating optimal fluorophore-quencher combinations.
  • the results of a first comparison experiment, which are shown in Figure 6, show that the two-part system surprisingly works excellently despite the non-covalent connection between fluorophore and quencher via several nucleotides of the same molecule.
  • Using a base strand without marking also offers benefits. On the one hand, production is simplified and cheaper. On the other hand, various signal initiation molecules (or “signal molecules” for short), which in this case carry a fluorophore and quencher, can also be connected.
  • probe systems such as the TaqMan probe or molecular beacons can be connected to a base strand, so that signal generation remains target sequence-unspecific, but incorporates readily available state-of-the-art systems. Results of an example experiment with an exemplary embodiment are shown in FIG. 8; the simplified functional diagram of this representative exemplary embodiment can be found in FIG. 4A.
  • the reporter according to the invention offers the possibility of combining measurements via different channels, including base strands according to the invention can serve more than one receptor complex.
  • the receptor complexes are preferably arranged offset along the base strand in such a way that they activate different signaling complexes ( Figure 3).
  • the possible different color and/or intensity combinations of the respective markings can preferably encode different extended mediator sequences and thus different detected target sequences.
  • multiple target sequences can be detected simultaneously over different fluorescence intensities by using different target sequence-unspecific modular reporter complexes.
  • These target sequence-unspecific modular reporter complexes each have different mediator binding sites on the base strand, each with a different number of fluorescence and/or quencher markings.
  • Various exemplary embodiments of this are shown in Figures 5A, B and C. In this way, signals of different signal strength are generated by each type of signal complex, which thus become distinguishable in a fluorescence channel (see the results of an exemplary experiment in Figure 6).
  • Figure 9 describes a further embodiment of such a multiplex variant, in which in addition to two reporter complexes (Fig. 9A and B), each with a different mediator binding sequence and each with a different signal oligo binding site for each a different signal oligo, each with a different fluorophore, each of which upon activation A signal change is generated by the respective mediator in a different channel, and a third reporter complex (Fig. 9C) is added. This is activated by another different mediator, but also has two binding sites for the respective signal oligos of reporter complexes 1 and 2.
  • three DNA target sequences can be distinguished with only two available color channels in a detection device by using a mediator probe multiplex according to the invention.
  • PCR in the presence of the respective DNA sequence cleaves the respective mediator probe and the corresponding mediator is released. It is clear to the expert how a corresponding digital PCR should be carried out. Accordingly, the respective DNA sequence can be deduced from the respective change in the fluorescence signals: Table 3: Description of the multiplex approach, which results from the use of three modular reporter complexes that can bind two different signal oligos to different proportions.
  • Figure 1 The figure shows the Mediator probe cleavage during a PCR with activation of the Mediator in an embodiment of the invention.
  • Figure 2 shows the signal generation by activating the signal oligo on a target sequence-unspecific modular universal reporter complex in an embodiment of the invention.
  • B) shows the schematic structure of an embodiment of a target sequence-unspecific modular universal reporter complex according to the invention.
  • Figure 3 The figure shows a target sequence-unspecific modular reporter complex with alternating signal and receptor complexes, which, for example, enable mediator signal coding for monochrome multiplexing.
  • Figure 4 The figure shows exemplary embodiments for different marking positions of the fluorophore and quencher.
  • A) shows an example of cis-markings on the same signal oligo.
  • B) shows an example of trans markings.
  • Figure 5 The figure shows exemplary embodiments for modeling the signal strength (fluorescence signal strength) by multiple labeling of a target sequence-unspecific modular reporter complex or use of different quencher strengths.
  • A) shows an example of cis- Markings where a quencher and a fluorophore are present on a base strand and the signal oligo.
  • B) Shows another example of cis-labeling, with a quencher on the base strand and two signal oligos, each with a fluorophore.
  • C) shows an example of cis-labels, where two quenchers and two fluorophores are present on the base strand and signal oligos.
  • the figure demonstrates the optimal functionality of the two-part reporter according to the invention (curve with crosses) in comparison to the UR.
  • the advantageous properties of the reporter according to the invention also offer possibilities for multiplexing detection reactions, for example by using reporters according to the invention with labels with different fluorescence intensities, for example by a quencher and two fluorophores (multiplex variant 1, curve with circles) or by two quenchers and two fluorophores ( Multiplex variant 2, curve with squares).
  • NTCs Non-template Control
  • FIG 8 Comparison of the Universal Reporter (UR) of the prior art (curve with triangles) with the modular reporter according to the invention. Shown is an embodiment with an unlabeled base strand and a double-labeled signal oligo (curve with circles) that resembles a “TaqMan probe” (NTCs are each shown in dark gray).
  • the figure shows a further embodiment of a multiplex variant according to the invention, in which in addition to two reporter complexes (A and B), each of which has a different one
  • This is activated by another different mediator, but also has two binding sites for the respective signal oligos of reporter complexes 1 and 2.
  • Mediator probe PCR a novel approach for detection of real-time PCR based on label-free primary probes and standardized secondary universal fluorogenic reporters.
  • Clinical Chemistry 58 11
  • DOI 10.1373/clinchem.2O12.186734.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne un procédé de détection d'au moins une séquence d'acide nucléique cible au moyen d'une sonde médiatrice et d'au moins un complexe rapporteur modulaire non spécifique à une séquence cible, la séquence médiatrice libérée se liant à un site de liaison médiateur du complexe rapporteur modulaire non spécifique à une séquence cible, et étant étendue. Un changement de signal est initié et détecté. L'invention concerne également un kit pour la mise en oeuvre de ce procédé.
EP23721864.9A 2022-04-22 2023-04-21 Détection d'acide nucléique dans une pcr au moyen d'un complexe rapporteur modulaire non spécifique à une séquence cible Pending EP4511509A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22169463 2022-04-22
EP22191150.6A EP4265734A1 (fr) 2022-04-22 2022-08-19 Détection des acides nucléiques dans une pcr au moyen d'un complexe rapporteur modulaire non spécifique à la séquence cible
PCT/EP2023/060517 WO2023203230A1 (fr) 2022-04-22 2023-04-21 Détection d'acide nucléique dans une pcr au moyen d'un complexe rapporteur modulaire non spécifique à une séquence cible

Publications (1)

Publication Number Publication Date
EP4511509A1 true EP4511509A1 (fr) 2025-02-26

Family

ID=86329548

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23721864.9A Pending EP4511509A1 (fr) 2022-04-22 2023-04-21 Détection d'acide nucléique dans une pcr au moyen d'un complexe rapporteur modulaire non spécifique à une séquence cible

Country Status (3)

Country Link
US (1) US20250340928A1 (fr)
EP (1) EP4511509A1 (fr)
WO (1) WO2023203230A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119842874B (zh) * 2025-03-24 2025-06-13 北京百力格生物科技有限公司 非靶标依赖的检测靶基因中snp位点基因型的方法及其试剂盒

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006244035A1 (en) * 2005-05-11 2006-11-16 Stratagene California Snapback oligonucleotide probe
US9921154B2 (en) 2011-03-18 2018-03-20 Bio-Rad Laboratories, Inc. Multiplexed digital assays
MX340258B (es) 2011-01-11 2016-07-01 Seegene Inc Detección de secuencias de ácido nucleico objetivo mediante ensayo de escisión y extensión del pto.
DE102011055247A1 (de) 2011-11-10 2013-05-16 Albert-Ludwigs-Universität Freiburg Multianalyt-Reportersystem
RU2620958C2 (ru) * 2012-12-27 2017-05-30 Сиджен, Инк. Детекция нуклеиновокислотной последовательности-мишени в анализе с отсутствием гибридизации, зависящим от расщепления и удлинения зондирующего и метящего олигонуклеотида (рто)
CN110536968A (zh) * 2016-12-23 2019-12-03 阿尔伯特-路德维希-弗莱堡大学 两部分式中介探针

Also Published As

Publication number Publication date
WO2023203230A1 (fr) 2023-10-26
US20250340928A1 (en) 2025-11-06

Similar Documents

Publication Publication Date Title
DE69734283T2 (de) Met/fret markierte amplifikationsoligonukleotide und ihre vewendung in verfahren
DE69828908T2 (de) Fluorimetrisches system zum nachweis von nucleinsäuren
DE60118655T2 (de) Sonden und Methoden zum Nachweis von Nukleinsäuren
DE69531133T2 (de) Verfahren zur Dämpfung der Fluoreszene in Lösung von Fluoreszenzmarkierten Oligonucleotidsonden
EP3559275A1 (fr) Sonde médiatrice en deux parties
EP3287528A1 (fr) Procede d'amplification d'acides nucleiques et kit d'execution
DE10338308B4 (de) Verfahren zum Nachweis von Cytosin-Methylierungen in DNA
DE60204874T2 (de) Verfahren zur nachweis von nukleinsäuren
DE19915141A1 (de) Detektion von Nucleinsäure-Amplifikaten
DE69427876T2 (de) Methode zur detektion einer gezielten nukleinsäure
DE69902086T2 (de) Verfahren zum nachweis von nukleinsäure-zielsequenzen mittels in vitro transkription von einem rna-promoter
DE602005000485T2 (de) Nukleinsäurenachweisverfahren mittels mehreren Paaren von Donorflurophoren und Quenchemolekülen in derselben Sonde
DE69834506T2 (de) Fluorometrisches verfahren zur überwachung und zum nachweis der amplifizierung von nucleinsäuren
DE112020000525B4 (de) Verfahren zum nachweis mehrerer ziele basierend auf einer einzigen nachweissonde unter verwendung eines markierungs-sequenz-snp
EP2467498A1 (fr) Procédé de détection d'acides nucléiques cibles
EP1109935B1 (fr) Representation differentielle en deux couleurs utilise comme procede de detection de genes regules
WO2023203230A1 (fr) Détection d'acide nucléique dans une pcr au moyen d'un complexe rapporteur modulaire non spécifique à une séquence cible
EP3350340B1 (fr) Test de vérification de produits d'amplification primaires d'acides nucléiques dans un processus réactionnel continu et analyse directe au moyen d'un procédé immunochromatographique
WO2017046192A1 (fr) Test de vérification de produits d'amplification primaires d'acides nucléiques au cours d'un processus réactionnel continu et analyse directe au moyen d'un procédé électrophorétique
EP4265734A1 (fr) Détection des acides nucléiques dans une pcr au moyen d'un complexe rapporteur modulaire non spécifique à la séquence cible
WO2023203227A1 (fr) Amplification par pcr multiplexe par l'intermédiaire de molécules rapporteurs indépendantes des séquences cibles avec des intensités de signal différenciables
EP4265735A1 (fr) Multiplexage pcr par molécules rapporteurs indépendantes de la séquence cible à l'aide de récepteurs pouvant être distingués
DE60017750T2 (de) Amplifizierungsverfahren zum Nachweis von zu bestimmenden Nucleinsäuren und Anwendung von Flourszenzenergieübertragung
DE60319146T2 (de) Zusammensetzungen und verfahren für den nachweis von polynukleotiden
WO2012069484A2 (fr) Procédé de détection qualitative et quantitative de séquences d'acides nucléiques spécifiques en temps réel

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20241119

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HAHN-SCHICKARD-GESELLSCHAFTFUER ANGEWANDTE FORSCHUNG E. V.